AWM
ABBV icon

Apollon Wealth Management’s AbbVie ABBV Stock Holding History

Apollon Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8M Buy
122,381
+2,766
+2% +$595K 0.37% 55
2026
Q1 		$26M Buy
119,615
+7,638
+7% +$1.69M 0.42% 46
2025
Q4 		$25.6M Buy
111,977
+29,932
+36% +$6.82M 0.44% 41
2025
Q3 		$19M Buy
82,045
+1,528
+2% +$311K 0.34% 58
2025
Q2 		$14.9M Buy
80,517
+508
+0.6% +$94.4K 0.3% 67
2025
Q1 		$16.8M Buy
80,009
+779
+1% +$151K 0.37% 53
2024
Q4 		$14.1M Buy
79,230
+8,209
+12% +$1.51M 0.32% 63
2024
Q3 		$14M Buy
71,021
+2,590
+4% +$483K 0.4% 51
2024
Q2 		$11.7M Buy
68,431
+1,156
+2% +$191K 0.36% 55
2024
Q1 		$12.3M Buy
67,275
+444
+0.7% +$76.5K 0.39% 51
2023
Q4 		$10.4M Buy
66,831
+18,902
+39% +$2.76M 0.36% 53
2023
Q3 		$7.14M Sell
47,929
-309
-0.6% -$45.4K 0.36% 57
2023
Q2 		$6.5M Sell
48,238
-2,798
-5% -$410K 0.31% 67
2023
Q1 		$8.13M Buy
51,036
+3,935
+8% +$602K 0.5% 36
2022
Q4 		$7.61M Buy
47,101
+5,582
+13% +$856K 0.54% 33
2022
Q3 		$5.57M Buy
41,519
+1,670
+4% +$240K 0.46% 39
2022
Q2 		$6.1M Sell
39,849
-167
-0.4% -$25.5K 0.51% 36
2022
Q1 		$6.49M Sell
40,016
-2,219
-5% -$322K 0.46% 39
2021
Q4 		$5.72M Buy
42,235
+17,668
+72% +$2.09M 0.43% 46
2021
Q3 		$2.65M Buy
24,567
+10,118
+70% +$1.16M 0.36% 54
2021
Q2 		$1.63M Sell
14,449
-221
-2% -$24.9K 0.29% 62
2021
Q1 		$1.59M Buy
14,670
+12,167
+486% +$1.3M 0.31% 64
2020
Q4 		$268K Sell
2,503
-1,698
-40% -$163K 0.07% 166
2020
Q3 		$368K Buy
4,201
+2,028
+93% +$191K 0.17% 102
2020
Q2 		$213K Buy
+2,173
New +$191K 0.12% 98

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Apollon Wealth Management's ABBV Position: Q2 2026 in Review

Apollon Wealth Management increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $595K and bringing the position to 122,381 shares worth $30.8M. The position accounts for 0.37% of the portfolio, ranked #55.

Apollon Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 1,333 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Apollon Wealth Management held 122,381 shares of AbbVie worth $30.8M as of Q2 2026.
  • Apollon Wealth Management bought 2,766 AbbVie shares in Q2 2026, an estimated $595K.
  • AbbVie made up 0.37% of Apollon Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Apollon Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 1,333 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.